REFERENCES
- Hughes DL. Trematodes, excluding schistosomes with special emphasis on Fasciola. Curr Top Microbiol Immunol 1985; 120: 241–60.
- WHO 1995. Control of foodborne trematode infections. Geneva: World Health Organization, Technical Report Series, No. 849.
- Hillyer GV, Apt W. Food-borne trematode infections in the Americas. Parasitol Today 1997; 13: 87–8.
- Triclabendazole and fascioliasis–a new drug to combat an age-old disease. WHO Fact Sheet 191 April 1998.
- Mas-Coma MS, Esteban JB, Bargues MD. Epidemiology of human fascioliasis: a review and proposed new classification. Bull World Health Organ 1999; 77: 340–6.
- Esteban JG, Bargues MD, Mas-Coma S. Geographical distribution, diagnosis and treatment of human fascioliasis: a review. Res Rev Parasitol 1998; 58: 13–48.
- Price TA, Tuazon CU, Simon GL. Fascioliasis: case reports and review. Clin Infect Dis 1993; 17: 426–30.
- Farid Z, Kamal M, Mansour N. Praziquantel and Fasciola hepatica infection. Trans R Soc Trop Med Hyg 1989; 83: 813–7.
- Farag HF, Salem A, El-Hifni SA, Kandil M. Bithionol (Bitin) treatment in established fascioliasis in Egyptians. J Trop Med Hyg 1988; 91: 240–4.
- Savioli L, Chitsulo L, Montresor A. New opportunities for the control of fascioliasis. Bull World Health Org 1999; 77: 300.
- Apt W, Aguilera X, Vega F, Miranda C, Zulantay I, Perez C, et al. Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response. Am J Trop Med Hyg 1995; 52: 532–5.
- López-Vélez R, Domínguez-Castellano, Garrón C. Successful treatment of human fascioliasis with triclabendazole., Eur J Clin Microbiol Infect Dis 1999; 18: 525–30.